Canonical ingredient
2H-1-Benzopyran-2-one, 6-(ß-D-glucopyranosyloxy)-7-hydroxy-
ESCULIN
18 linked products
Official identifiers
CAS 531-75-9ChEBI CHEBI:4853InChI InChI=1S/C15H16O9/c16-5-10-12(19)13(20)14(21)15(24-10)23-9-3-6-1-2-11(18)22-8(6)4-7(9)17/h1-4,10,12-17,19-21H,5H2/t10-,12-,13+,14-,15-/m1/s1InChIKey XHCADAYNFIFUHF-TVKJYDDYSA-NKEGG_COMPOUND C09264NHPID_ID 7184SMILES O=c1ccc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2o1
Names and synonyms
- 2H-1-Benzopyran-2-one, 6-(ß-D-glucopyranosyloxy)-7-hydroxy- (en)
- esculin (en)
- Esculine (fr)
- Esculine (fr-CA)
Source-scoped chemical properties
Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.
- canada dsl listing
- listed
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl bioaccumulative
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl inherently toxic aquatic
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets cepa categorization
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets environmental
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets human health
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl persistent
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl substance category
- Organics
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Documented origins
No origin has been proven yet by an explicit source.
Documented organizations
No organization has been proven yet by an explicit source.
Documented transformations
No transformation step has been proven yet by an explicit source.
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
AESCULINUM GRANULE(6DH-30DH)
6 · DH
ODAN PROCTOMYXIN HC
1 · %
ODAN PROCTOMYXIN HC SUPPOSITORIES
10 · MG
PROCTOL OINTMENT
1 · %
PROCTOL SUPPOSITORIES
10 · MG
PROCTOSEDYL
1 · %
PROCTOSEDYL
10 · MG
PROCTOSEDYL OINTMENT
10 · MG · G
PROCTOSEDYL OINTMENT
10 · MG · G
PROCTOSEDYL SUP
10 · MG
PROCTOSEDYL SUPPOSITORIES
10 · MG
PROCTOSONE ONT
1 · % · %
PROCTOSONE SUP
10 · MG · SUP
RATANHIA COMP. DROPS
19 · D · 19 · D
SCIAT HP
30 · X
SCIATINIX HP
30 · X
TEVA-PROCTOSONE
1 · %
TEVA-PROCTOSONE
10 · MG